205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.91%
Revenue decline while MCHP shows 5.97% growth. Joel Greenblatt would examine competitive position erosion.
-4.02%
Cost reduction while MCHP shows 6.40% growth. Joel Greenblatt would examine competitive advantage.
6.12%
Similar gross profit growth to MCHP's 5.56%. Walter Schloss would investigate industry dynamics.
7.10%
Margin expansion while MCHP shows decline. John Neff would investigate competitive advantages.
-6.71%
R&D reduction while MCHP shows 1.85% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.26%
Operating expenses growth above 1.5x MCHP's 4.48%. Michael Burry would check for inefficiency.
-0.18%
Total costs reduction while MCHP shows 5.73% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-136.84%
D&A reduction while MCHP shows 7.83% growth. Joel Greenblatt would examine efficiency.
-136.71%
EBITDA decline while MCHP shows 7.09% growth. Joel Greenblatt would examine position.
-138.89%
EBITDA margin decline while MCHP shows 1.05% growth. Joel Greenblatt would examine position.
-72.73%
Operating income decline while MCHP shows 6.71% growth. Joel Greenblatt would examine position.
-74.32%
Operating margin decline while MCHP shows 0.70% growth. Joel Greenblatt would examine position.
164.10%
Other expenses growth above 1.5x MCHP's 51.27%. Michael Burry would check for concerning trends.
282.35%
Pre-tax income growth exceeding 1.5x MCHP's 7.57%. David Dodd would verify competitive advantages.
285.88%
Pre-tax margin growth exceeding 1.5x MCHP's 1.51%. David Dodd would verify competitive advantages.
266.67%
Tax expense growth above 1.5x MCHP's 7.58%. Michael Burry would check for concerning trends.
372.73%
Net income growth exceeding 1.5x MCHP's 7.57%. David Dodd would verify competitive advantages.
377.09%
Net margin growth exceeding 1.5x MCHP's 1.51%. David Dodd would verify competitive advantages.
200.00%
EPS growth exceeding 1.5x MCHP's 7.07%. David Dodd would verify competitive advantages.
200.00%
Diluted EPS growth exceeding 1.5x MCHP's 7.07%. David Dodd would verify competitive advantages.
0.25%
Share count reduction exceeding 1.5x MCHP's 0.89%. David Dodd would verify capital allocation.
0.48%
Diluted share reduction below 50% of MCHP's 0.89%. Michael Burry would check for concerns.